磁共振弹性成像定量评估常染色体隐性多囊肾病肝病严重程度
横断面研究纳入9例常染色体隐性多囊肾病(ARPKD)患者和14名健康对照,评估肝脏和脾脏磁共振弹性成像(MRE)能否测量先天性肝纤维化(CHF)和门静脉高压(pHTN)的严重程度,并分析肝脏MRE与超声弹性成像的相关性。结果显示ARPKD患者肝脏MRE硬度高于对照组(2.55 vs 1.92 kPa,p=0.008),合并pHTN者肝脏MRE硬度高于无pHTN者(3.60 vs 2.49 kPa,p=0.05);肝脏MRE鉴别ARPKD与对照的敏感度78%、特异度93%(阈值2.48 kPa,ROC曲线下面积0.83,95%CI 0.63-1.00)。作者认为肝脏MRE可能是有用的定量方法。
要点
- ARPKD患者肝脏MRE硬度中位数2.55 kPa,高于健康对照的1.92 kPa(p=0.008)。
- 合并门静脉高压的ARPKD患者肝脏MRE硬度中位数3.60 kPa,高于无门静脉高压者的2.49 kPa(p=0.05)。
- 肝脏MRE鉴别ARPKD与对照:阈值2.48 kPa时敏感度78%、特异度93%,ROC曲线下面积0.83(95%CI 0.63-1.00)。
诊断标准与关键数值
- 肝脏MRE鉴别ARPKD与对照:阈值2.48 kPa时敏感度78%、特异度93%,ROC曲线下面积0.83(95%CI 0.63-1.00)。
- ARPKD患者肝脏MRE硬度中位数2.55 kPa vs 健康对照1.92 kPa(p=0.008)。
- 合并门静脉高压的ARPKD患者肝脏MRE硬度中位数3.60 kPa vs 无门静脉高压者2.49 kPa(p=0.05)。
- 脾脏MRE硬度在ARPKD与对照间无差异。
- 肝脏MRE与超声弹性成像测量值强相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate whether liver and spleen magnetic resonance elastography (MRE) can measure the severity of congenital hepatic fibrosis (CHF) and portal hypertension (pHTN) in individuals with autosomal recessive polycystic kidney disease (ARPKD), and to examine correlations between liver MRE and ultrasound (US) elastography.
METHODS: Cross-sectional study of nine individuals with ARPKD and 14 healthy controls. MRE was performed to measure mean liver and spleen stiffness (kPa); US elastography was performed to measure point shear wave speed (SWS) in both liver lobes. We compared: (1) MRE liver and spleen stiffness between controls vs. ARPKD; and (2) MRE liver stiffness between participants with ARPKD without vs. with pHTN, and examined correlations between MRE liver stiffness, spleen length, platelet counts, and US elastography SWS. Receiver operating characteristic (ROC) analysis was performed to examine diagnostic accuracy of liver MRE.
RESULTS: Participants with ARPKD (median age 16.8 [IQR 13.3, 18.9] years) had higher median MRE liver stiffness than controls (median age 14.7 [IQR 9.7, 16.7 years) (2.55 vs. 1.92 kPa, p = 0.008), but MRE spleen stiffness did not differ. ARPKD participants with pHTN had higher median MRE liver stiffness than those without (3.60 kPa vs 2.49 kPa, p = 0.05). Liver MRE and US elastography measurements were strongly correlated. To distinguish ARPKD vs. control groups, liver MRE had 78% sensitivity and 93% specificity at a proposed cut-off of 2.48 kPa [ROC area 0.83 (95% CI 0.63-1.00)].
CONCLUSION: Liver MRE may be a useful quantitative method to measure the severity of CHF and pHTN in individuals with ARPKD.
引用
- Hartung EA, Calle-Toro JS, Lopera CM, et al. Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease. Abdom Radiol (NY). 2020. PMID: 32757071. doi:10.1007/s00261-020-02694-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。